About Eli Miloslavsky, MD

Dr. Miloslavsky specializes in the diagnosis and treatment of vasculitis and other systemic diseases such as inflammatory myopathy and sarcoidosis among others.  He is the Co-Director of the MGH Vasculitis and Glomerulonephritis center. His research has focused on outcomes and treatment of ANCA-Associated Vasculitis and glucocorticoid toxicity.  

Dr. Miloslavsky also has a strong interest in medical education.  He currently teaches at MGH and Harvard Medical School where he holds several leadership roles. Within medical education his research has focused on simulation, consultative medicine, science education and peer teaching. 

Dr. Miloslavsky graduated from the Icahn School of Medicine at Mount Sinai and completed his internal medicine residency and rheumatology fellowship at MGH.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Mass General Rheumatology
55 Fruit St.
Yawkey Center for Outpatient Care
Suite 2C
Boston, MA 02114
Phone: 617-726-7938

Medical Education

  • MD, Mount Sinai School of Medicine
  • Residency, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Internal Medicine, American Board of Internal Medicine
  • Rheumatology, American Board of Internal Medicine

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Publications

  • Wallace ZS, Miloslavsky EM. Management of ANCA associated vasculitis. British Medical Journal 2020 Mar 18;368:m421

    Miloslavsky EM, Niles JL, Wallace ZS et al. Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial. Seminars in Arthritis and Rheumatism 2018 Oct;48(2):288-292.

    Miloslavsky EM, Naden, RP, Bijlsma JW, et al. Development of a Glucocorticoid Toxicity Index (GTI) Using Multi-Criteria Decision Analysis. Annals of the Rheumatic Diseases 2017 Mar;76(3):543-546.

    Miloslavsky EM, Specks U, Merkel PA et al. Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatology. 2013 Sep;65(9):2441-9

    Other publications can be found at:https://pubmed.ncbi.nlm.nih.gov/?term=miloslavsky%20e&sort=date

Reviews: Comments and Ratings